Ticker: ACON

Aclarion, Inc. (NASDAQ: ACON) - Quick operational & income-statement snapshot Short take: management executed multiple equity financings in Q1 2025, dramatically increasing cash on the balance sheet and extending runway, while commercial traction in the UK produced revenue growth. At the same tim...

Aclarion, Inc. (NASDAQ: ACON) Aclarion, Inc. has reported its financial results for the first quarter of 2025, revealing both positive growth and challenges. The company specializes in healthcare technology, particularly leveraging magnetic resonance spectroscopy to enhance clinical treatments. K...